| Literature DB >> 17384780 |
Chad Lewis1, Irwin H Suffet, Katherine Hoggatt, Beate Ritz.
Abstract
OBJECTIVES: We evaluated the association between drinking-water disinfection by-products and preterm births using improved exposure assessment and more appropriate analysis methods than used in prior studies.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17384780 PMCID: PMC1831522 DOI: 10.1289/ehp.9394
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Demographic characteristics of mothers and their singleton infants in selected Massachusetts communities served by a single surface–supplied drinking water utility, 1999–2001.
| Characteristic | Study population [no. (%)] | Percent preterm ( |
|---|---|---|
| Total | 37,498 (100) | 7.5 |
| Sex | ||
| Male | 19,219 (51.3) | 7.8 |
| Female | 18,279 (48.7) | 7.1 |
| Age (years) | ||
| < 20 | 2,136 (5.7) | 9.2 |
| 20 to 29 | 13,937 (37.2) | 7.7 |
| 30 to 34 | 12,671 (33.8) | 6.9 |
| 35 to 39 | 7,144 (19.1) | 7.5 |
| ≥ 40 | 1,610 (4.3) | 8.3 |
| Race | ||
| Caucasian | 21,945 (58.5) | 6.5 |
| African American | 5,846 (15.6) | 10.4 |
| Hispanic | 5,957 (15.9) | 9.1 |
| Asian | 3,716 (9.9) | 6.3 |
| Other | 34 (0.1) | 8.8 |
| Prenatal care | ||
| Adequate | 27,941 (74.5) | 7.0 |
| Intermediate | 4,995 (13.3) | 9.9 |
| Inadequate | 992 (2.6) | 10.7 |
| No prenatal care | 48 (0.1) | 25.0 |
| Unknown | 3,522 (9.4) | 7.2 |
| Parity | ||
| 1 | 18,235 (48.6) | 7.9 |
| 2 to 3 | 16,883 (45.0) | 6.8 |
| 4 to 5 | 2,069 (5.5) | 9.5 |
| ≥ 6 | 311 (0.8) | 9.3 |
| Maternal disease factor present | ||
| None | 31,556 (84.2) | 6.5 |
| ≥ 1 | 5,942 (15.8) | 12.9 |
| Prenatal care payment source | ||
| Private or HMO | 25,708 (68.6) | 6.6 |
| Government or Healthy Start | 11,790 (31.4) | 9.6 |
Kessner Index (Kessner et al. 1973)
Study population and percent preterm births by TTHM (μg/L) level averaged over different gestational periods.
| TTHM (μg/L) | Study population [no. (%)] | Percent preterm ( |
|---|---|---|
| Total | 37,498 (100) | 7.5 |
| First trimester | ||
| < 40 | 10,831 (28.9) | 7.2 |
| 40 to < 60 | 17,588 (46.9) | 7.6 |
| ≥ 60 | 9,079 (24.2) | 7.7 |
| Second trimester | ||
| < 40 | 10,604 (28.3) | 7.9 |
| 40 to < 60 | 16,059 (42.8) | 7.5 |
| ≥ 60 | 10,835 (28.9) | 7.2 |
| Previous 4-week average | ||
| < 40 | 10,300 (27.5) | 8.2 |
| 40 to < 60 | 13,031 (34.8) | 7.1 |
| ≥ 60 | 14,167 (37.8) | 7.4 |
| Pregnancy average | ||
| < 40 | 7,222 (19.3) | 8.2 |
| 40 to < 60 | 21,399 (57.1) | 7.3 |
| ≥ 60 | 8,877 (23.7) | 7.4 |
Adjusteda HRs (95% CIs) for preterm birth and gestational age-specific TTHM exposure averages by race and ancestry.
| TTHM (μg/L) | 1st Trimester | 2nd Trimester | 4-Week risk sets | Pregnancy average |
|---|---|---|---|---|
| All races ( | ||||
| < 40 | 1.00 | 1.00 | 1.00 | 1.00 |
| 40 to < 60 | 1.02 (0.92–1.13) | 0.87 (0.77–0.99) | 1.00 (0.87–1.15) | 0.92 (0.82–1.02) |
| ≥ 60 | 1.00 (0.88–1.14) | 0.82 (0.71–0.94) | 1.13 (0.95–1.35) | 0.85 (0.74–0.97) |
| Per 10 μg/L | 0.98 (0.95–1.02) | 0.95 (0.92–0.99) | 1.01 (0.97–1.06) | 0.95 (0.91–0.99) |
| Caucasians ( | ||||
| < 40 | 1.00 | 1.00 | 1.00 | 1.00 |
| 40 to < 60 | 0.97 (0.84–1.12) | 0.93 (0.77–1.11) | 0.97 (0.79–1.18) | 0.92 (0.79–1.06) |
| ≥ 60 | 1.04 (0.87–1.24) | 0.86 (0.71–1.05) | 1.14 (0.90–1.45) | 0.81 (0.67–0.99) |
| Per 10 μg/L | 0.99 (0.94–1.05) | 0.95 (0.90–1.00) | 1.04 (0.97–1.10) | 0.96 (0.91–1.03) |
| African American ( | ||||
| < 40 | 1.00 | 1.00 | 1.00 | 1.00 |
| 40 to < 60 | 1.27 (1.00–1.60) | 0.73 (0.56–0.96) | 0.78 (0.57–1.07) | 0.95 (0.74–1.20) |
| ≥ 60 | 1.13 (0.84–1.52) | 0.62 (0.46–0.84) | 1.00 (0.69–1.45) | 0.77 (0.57–1.05) |
| Per 10 μg/L | 1.01 (0.93–1.10) | 0.89 (0.82–0.96) | 0.98 (0.89–1.08) | 0.90 (0.81–0.99) |
| Hispanic ( | ||||
| < 40 | 1.00 | 1.00 | 1.00 | 1.00 |
| 40 to < 60 | 0.97 (0.75–1.24) | 1.07 (0.80–1.43) | 1.59 (1.15–2.21) | 0.87 (0.68–1.12) |
| ≥ 60 | 0.86 (0.63–1.17) | 1.07 (0.78–1.46) | 1.63 (1.09–2.43) | 1.00 (0.73–1.36) |
| Per 10 μg/L | 0.95 (0.87–1.04) | 1.04 (0.96–1.14) | 1.05 (0.95–1.17) | 1.01 (0.91–1.11) |
| Asian ( | ||||
| < 40 | 1.00 | 1.00 | 1.00 | 1.00 |
| 40 to < 60 | 0.94 (0.65–1.34) | 0.65 (0.42–1.02) | 0.80 (0.49–1.29) | 0.89 (0.62–1.26) |
| ≥ 60 | 0.77 (0.49–1.22) | 0.72 (0.44–1.20) | 0.68 (0.35–1.29) | 0.86 (0.54–1.37) |
| Per 10 μg/L | 0.90 (0.79–1.03) | 0.95 (0.82–1.09) | 0.88 (0.74–1.04) | 0.86 (0.74–1.01) |
HRs were adjusted for infant sex, marital status, adequacy of prenatal care, maternal age, maternal race/ethnicity, maternal education, parity, maternal smoking, prenatal care source of payment, conception season, birth season, per-capita income, previous preterm or SGA infant, previous trimester TTHM exposure, and the presence of one or more maternal disease factors including lung disease, diabetes, eclampsia, hydramnios, chronic hypertension, pregnancy-related hypertension, incompetent cervix, renal disease, uterine bleeding, and inappropriate maternal weight gain/loss.
Crude and adjusteda HRs (95% CIs) for preterm birth and gestational age specific TTHM exposure averages by payment source for prenatal care.
| 2nd Trimester
| 4 Weeks before birth
| |||
|---|---|---|---|---|
| TTHM (μg/L) | Government | Private | Government | Private |
| Crude | ||||
| < 40 | 1.00 | 1.00 | 1.00 | 1.00 |
| 40 to < 60 | 0.88 (0.75–1.02) | 0.92 (0.81–1.04) | 1.01 (0.84–1.23) | 0.92 (0.79–1.08) |
| ≥ 60 | 0.84 (0.71–0.99) | 0.88 (0.77–1.01) | 1.19 (0.98–1.44) | 0.94 (0.80–1.10) |
| Adjusted | ||||
| < 40 | 1.00 | 1.00 | 1.00 | 1.00 |
| 40 to < 60 | 0.88 (0.72–1.07) | 0.87 (0.74–1.03) | 1.07 (0.85–1.34) | 0.96 (0.80–1.15) |
| ≥ 60 | 0.83 (0.67–1.04) | 0.82 (0.69–0.99) | 1.39 (1.06–1.81) | 1.00 (0.79–1.25) |
| Per 10 μg/L | 0.96 (0.91–1.02) | 0.95 (0.90–1.00) | 1.03 (0.96–1.11) | 1.00 (0.95–1.06) |
HRs were adjusted for infant sex, marital status, adequacy of prenatal care, maternal age, maternal race and ancestry, maternal education, parity, maternal smoking, conception season, birth season, per-capita income, previous preterm or SGA infant, previous-trimester TTHM exposure, and the presence of one or more maternal disease factors including lung disease, diabetes, eclampsia, hydramnios, chronic hypertension, pregnancy-related hypertension, incompetent cervix, renal disease, uterine bleeding, and inappropriate maternal weight gain/loss.
Source of payment was government or Healthy Start.
Source of payment was private or health maintenance organization.